Beat Anxiety: Surprising Fix Discovered

Person lying on a bed with a pillow over their head, surrounded by medication

A randomized clinical trial has pinpointed exactly how long you need to listen to specially engineered music to meaningfully dial down anxiety—and the answer isn’t what most wellness gurus would guess.

Story Snapshot

Toronto Metropolitan University researchers found 24 minutes of music embedded with auditory beat stimulation reduced anxiety with medium effect sizes in a dose-response trial of 144 adults already on anxiety medication.
The 24-minute session outperformed both 12-minute and pink-noise controls and matched the benefit of 36 minutes, establishing an optimal balance between efficacy and practicality.
Effects targeted both cognitive anxiety—racing thoughts and worry—and somatic anxiety—physical symptoms like tension and rapid heartbeat.
The intervention is positioned as a complementary, non-drug tool to layer on top of existing treatments, not a replacement for medication or therapy.

The Sweet Spot Science Behind 24 Minutes

Researchers Danielle Mullen and Frank Russo at Toronto Metropolitan University didn’t stumble onto the 24-minute threshold by accident. They designed a randomized clinical trial explicitly to map the dose-response curve of music therapy for anxiety. One hundred forty-four participants with moderate trait anxiety, all already taking anxiety medication, were assigned to listen to either 12, 24, or 36 minutes of music embedded with auditory beat stimulation, or 24 minutes of pink noise as a control. The music tracks used two slightly different frequencies delivered separately to each ear, creating a perceived beat intended to entrain brainwaves toward relaxation-associated frequencies like alpha and theta waves.

All three music-plus-ABS conditions beat pink noise, but the 24-minute group showed the strongest overall anxiety reduction. That duration performed on par with 36 minutes and significantly better than 12 minutes, suggesting diminishing returns beyond the half-hour mark. Russo, who also serves as Chief Science Officer at LUCID, a digital therapeutics startup spun out of TMU, described 24 minutes as long enough to meaningfully shift anxiety levels but short enough that people can realistically carve out the time in daily routines. The finding replicates a 2022 study by the same team, strengthening confidence that this isn’t a fluke.

Why Auditory Beat Stimulation Amplifies the Effect

Generic relaxing music has a decent track record for calming nerves. Meta-analyses show that roughly 22 minutes of music listening on average reduces self-reported anxiety in non-clinical populations, and controlled hospital studies document drops in cortisol and heart rate after 15 to 30 minutes of calm, structured soundtracks. Auditory beat stimulation takes that foundation and engineers it for a specific neurological target. The technique relies on brainwave entrainment, the idea that external rhythmic stimuli can nudge the brain’s electrical activity toward particular frequency bands associated with relaxation or focus.

Previous research on binaural beats and similar audio interventions has been mixed, with many small trials showing promise but lacking the rigor of larger, randomized designs. The TMU program stands out because it tested ABS-embedded music in a formal dose-response framework with participants who represent real-world treatment-seeking populations—people already on medication who still experience residual symptoms. That specificity matters. It demonstrates that the intervention adds measurable benefit even when pharmacotherapy is already in play, positioning music-plus-ABS as a complement rather than a competitor to standard care.

Practical Implications and Remaining Unknowns

The immediate takeaway is accessible and low-barrier. Anyone with headphones and a smartphone can access 24-minute ABS-embedded playlists, and the intervention carries negligible risk compared to adding or adjusting medication. Clinicians could recommend these sessions as part of psychoeducation or digital self-management packages, especially in settings where access to psychotherapy is limited or wait times are long. For individuals juggling medication side effects or looking for additional coping tools, a half-hour music session before a stressful meeting or at bedtime is straightforward to integrate.

That said, the evidence remains tethered to single-session, laboratory-tested efficacy. The trial measured anxiety immediately post-listening, and no published longitudinal data yet exists on whether repeated daily sessions compound benefits over weeks or months, or whether effects fade without ongoing use. The participant pool was also narrow—adults with moderate trait anxiety who were medicated—so questions remain about efficacy in unmedicated clinical populations, adolescents, or culturally diverse groups. Meta-analytic reviews note moderate, consistent reductions across audio-based anxiety interventions but caution that effect sizes are middling, not transformative.

Commercial and Regulatory Crossroads Ahead

Russo’s dual role as TMU professor and LUCID Chief Science Officer introduces a natural tension between academic rigor and commercial incentive. LUCID is positioning ABS-music interventions as digital therapeutics, a category that increasingly attracts regulatory scrutiny and payer interest. If future multi-week, real-world trials replicate and extend these findings, the company could seek formal approvals or insurance reimbursement, moving the product from wellness app to prescribed digital therapeutic. That shift would require navigating FDA or equivalent oversight, transparency around conflicts of interest, and standards for evidence that exceed typical app-store wellness claims.

Just 24 minutes of specially designed music could significantly reduce anxiety
┈┈┈┈┈┈┈┈ ▶︎•၊၊||၊|။|||||။၊|။•
A randomized clinical trial found that listening to specially designed music for 24 minutes can significantly reduce anxiety. The music uses auditory beat… pic.twitter.com/eytGDpWAil

— Science Joy (@InsideOurBodies) March 16, 2026

The broader mental health app ecosystem is already responding. Wellness platforms are curating “24-minute anxiety relief” playlists, citing the TMU research, and music streaming services may follow suit. The risk is that variable-quality imitators will flood the market with generic relaxing music branded as evidence-based ABS interventions, diluting the signal and confusing consumers. The TMU-LUCID program’s contribution may ultimately be less about discovering a magic number and more about setting a precedent for rigorous, dose-response research in a field littered with anecdotal claims and underpowered studies.